Sector
1090 stories · page 41 of 55
“Our hope is that both the PTSD Study and the Depression Study yield significant results, which enable not only our clinicians but those in other clinics as well as to improve the patient experience and alleviate chronic pain, depression an
nib is Australia’s fourth-largest private health insurer and provides private health insurance coverage to over 1.2 million policyholders
The company is using its neuro-visual performance platform to test, analyze, track and report on individual cognitive results
The company said that the trial will be conducted in association with a clinic operator at its facilities in Miami, Florida
The company said ketamine has been shown to provide rapid and significant antidepressant effects in individuals with unipolar and bipolar treatment-resistant depression (TRD), and can also rapidly reduce suicidal thoughts
Ibogaine is a naturally occurring psychedelic substance with dissociative properties and preliminary research ndicates that it may help counter drug addiction
The US FDA has granted Fast Track Designation for REQORSA for non-small cell lung cancer in combination with AstraZeneca's Tagrisso for patients with EFGR mutations whose tumors progressed after treatment with Tagrisso alone
Pathway is now reporting that it will expand the rollout to New Brunswick, Prince Edward Island, and Newfoundland, introducing the MCMS to Sobeys' Canadian pharmacy locations
A patient walking into a Ketamine One clinic in North America can expect to be offered a range of treatments, including psychedelic-assisted options, from a skilled medical professional and guided by cutting-edge technology as part of the t
Lakmaaker has more than 20 years of executive experience, including in financial and corporate communications, corporate finance and marketing
Ketamine One will leverage its experience in ketamine-assisted therapies and innovative treatments, including integrating immersive virtual reality, towards creating a first-of-its-kind healing experience specifically for veterans suffering
NASDAQ-listed Enveric Biosciences Inc. announced on May 24, 2021, that it has entered into a definitive agreement for an all-stock transaction to acquire the biotechnology company
The company's Software-as-a-Service (SaaS) revenue comprises about 75% of its total revenue for the year, which is projected to exceed C$1.5 million
PCSG, practising since 2006 and with a team of 35 health professionals, provides individual psychotherapy, couple/family therapy, psychological, as well as psycho-educational assessment and intervention for children, youth and adults
The company said the arrangement with Illumma LLC “bolsters the company’s proposed network of six clinics” in the US
Steven McAuley, chairman and CEO of Empower Clinics said: "This is getting exciting, we are onto something special, The Medi-Collective, it's a launch!"
Pathway said the acquisition adds approximately 4,000 new, active patients to the company's existing base of over 55,000 medical cannabis patients and expands its telemedicine footprint in several provinces including British Columbia and th
“We have developed so much experience over the years through the cannabis industry and we genuinely believe we can now bring that to bear on the development of the psychedelics field in Australia,” says MD.
Cognetivity’s tool is a cognitive testing platform that offers a five-minute, computerized assessment that is suited to long-term mental health monitoring
The company, which is focused on treatments for depression and related conditions, said revenue for the three months came in at C$407,075
